Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 179, Issue 10, Pages 2100-2107Publisher
WILEY
DOI: 10.1111/bph.15594
Keywords
inflammation; neutrophils; platelets; resolution pharmacology; thromboinflammation; thrombosis
Categories
Funding
- Royal Society Wolfson Foundation [RSWF\R3\183001]
Ask authors/readers for more resources
The pathophysiology of COVID-19 is complex, with multiple systems contributing to thrombosis and inflammation. Understanding the role of the immune system in different patient cohorts is crucial for developing novel therapeutic targets and drug repurposing strategies.
Since the start of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, a disease that has become one of the world's greatest global health challenges, the role of the immune system has been at the forefront of scientific studies. The pathophysiology of coronavirus disease 2019 (COVID-19) is complex, which is evident in those at higher risk for poor outcome. Multiple systems contribute to thrombosis and inflammation seen in COVID-19 patients, including neutrophil and platelet activation, and endothelial dysfunction. Understanding how the immune system functions in different patient cohorts (particularly given recent emerging events with the Oxford/AstraZeneca vaccine) is vital to understanding the pathophysiology of this devastating disease and for the subsequent development of novel therapeutic targets and to facilitate possible drug repurposing strategies that could benefit society on a global scale.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available